May 2 (Reuters) - Generic drugmaker Actavis Inc, formerly known as Watson Pharmaceuticals , reported an adjusted quarterly profit that beat market estimates, helped by new products, and the company raised its earnings forecast for the full year.
Report: Merck Analyst Report: Mylan Technologies MYL Analyst Report: Teva Pharmaceuticals Analyst Report: Watson Pharmaceuticals WPI Rethinking Title Insurer Moat, Risk Ratings Analyst Jim Ryan reduced the moat rating and increased the risk
Now trading under its official new name, Actavis ACT (formerly Watson Pharmaceuticals ) highlighted its long-term growth strategy and presented expectations for the current quarter and upcoming 2013 results at its
Jan 25 (Reuters) - Actavis Inc, the generic drugmaker previously known as Watson Pharmaceuticals , said on Friday that it expected earnings to rise at least 30 percent in 2013 as it expands globally, but its outlook still came in short of analysts' expectations.
Watson Pharmaceuticals ( WPI ) announces plans to restructure operations at its Corona, California facility. As such, manufacturing and related support functions
Dec 28 (Reuters) - Watson Pharmaceuticals Inc said on Friday it has applied for U.S. approval to market a generic version of Velcade, a treatment for multiple myeloma made by Takeda Pharmaceutical Co.
Columbia Laboratories Inc.( CBRX ) confirmed that the U.S. Food and Drug Administration (FDA) had denied Watson Pharmaceuticals , Inc .'s ( WPI ) Formal Dispute Resolution Request (FDRR) related to its New Drug Application (NDA 22-139
By Peter Geschek : In 2013 Watson Pharmaceuticals ( WPI ) is changing its name to Actavis because the brand is more recognizable globally and to avoid confusion with other businesses
Watson Pharmaceuticals ( WPI ) Q3 2012 Earnings Call November 01, 2012 8:30 am ET Executives Lisa M. Defrancesco - Former Vice President of Global Investor
By Jason Merriam : Watson Pharmaceuticals ( WPI ) is a leading integrated global pharmaceutical company engaged in the development, manufacturing, marketing, sale, and distribution